Vitamin D and Diseases of Mineral Homeostasis: A Cyp24a1 R396W Humanized Preclinical Model of Infantile Hypercalcemia Type 1
Open Access
Abstract
Infantile hypercalcemia type 1 (HCINF1), previously known as idiopathic infantile hypercalcemia, is caused by mutations in the 25-hydroxyvitamin D 24-hydroxylase gene, CYP24A1. The R396W loss-of-function mutation in CYP24A1 is the second most frequent mutated allele observed in affected HCINF1 patients. We have introduced the site-specific R396W mutation within the murine Cyp24a1 gene in knock-in mice to generate a humanized model of HCINF1. On the C57Bl6 inbred background, homozygous mutant mice exhibited high perinatal lethality with 17% survival past weaning. This was corrected by crossbreeding to the CD1 outbred background. Mutant animals had hypercalcemia in the first week of life, developed nephrolithiasis, and had a very high 25(OH)D3 to 24,25(OH)2D3 ratio which is a diagnostic hallmark of the HCINF1 condition. Expression of the mutant Cyp24a1 allele was highly elevated while Cyp27b1 expression was abrogated. Impaired bone fracture healing was detected in CD1-R396w/w mutant animals. The augmented lethality of the C57Bl6-R396W strain suggests an influence of distinct genetic backgrounds. Our data point to the utility of unique knock-in mice to probe the physiological ramifications of CYP24A1 variants in isolation from other biological and environmental factors.Keywords
Funding Information
- ERA-Net (ERA-132931, R01 AR070544)
- National Institutes of Health (ERA-132931, R01 AR070544)
This publication has 38 references indexed in Scilit:
- Characterizing Antibody Cross-reactivity for Immunoaffinity Purification of Analytes prior to Multiplexed Liquid Chromatography–Tandem Mass SpectrometryClinical Chemistry, 2012
- Genetic Defect inCYP24A1, the Vitamin D 24-Hydroxylase Gene, in a Patient with Severe Infantile HypercalcemiaThe Journal of Clinical Endocrinology & Metabolism, 2012
- Mutations inCYP24A1and Idiopathic Infantile HypercalcemiaNew England Journal of Medicine, 2011
- Infantile Hypercalcemia and Hypercalciuria: New Insights into a Vitamin D-Dependent Mechanism and Response to Ketoconazole TreatmentThe Journal of Pediatrics, 2010
- Long-term follow-up of patients with idiopathic infantile hypercalcaemiaPediatric Nephrology, 2006
- Metabolism of Vitamin D3 by Human CYP27A1Biochemical and Biophysical Research Communications, 2000
- Persistent hypercalciuria and elevated 25-hydroxyvitamin D 3 in children with infantile hypercalcaemiaPediatric Nephrology, 1997
- Human 25-Hydroxyvitamin D3-24-Hydroxylase, a Multicatalytic EnzymeBiochemistry, 1996
- Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle developmentCell, 1992
- IDIOPATHIC HYPERCALCÆMIA IN INFANTSThe Lancet, 1953